 | • レポートコード：20QY06-05509 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、抗凝固剤のグローバル市場について種類別（血小板凝集阻害剤（PAI）、低分子ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接因子Xa阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他）、用途別（VTE、ACS/MI、AF、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・抗凝固剤市場の概要 ・世界の主要地域別抗凝固剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗凝固剤市場規模2015-2026：種類別（血小板凝集阻害剤（PAI）、低分子ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接因子Xa阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他） ・世界の抗凝固剤市場規模2015-2026：用途別（VTE、ACS/MI、AF、その他） ・抗凝固剤の北米市場規模2015-2020 ・抗凝固剤のヨーロッパ市場規模2015-2020 ・抗凝固剤の中国市場規模2015-2020 ・抗凝固剤の日本市場規模2015-2020 ・抗凝固剤の東南アジア市場規模2015-2020 ・抗凝固剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Sanofi、Bayer、Boehringer Ingelheim、Johnson & Johnson、Genentech (Roche)、AstraZeneca、Bristol-Myers Squibb、Aspen、Lilly、Otsuka、Pfizer、Daiichi Sankyo、The Medicines Company） ・抗凝固剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗凝固剤の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Anticoagulants Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Anticoagulants market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anticoagulants market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anticoagulants industry.
Based on our recent survey, we have several different scenarios about the Anticoagulants YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 885 million in 2019. The market size of Anticoagulants will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Anticoagulants market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Anticoagulants market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Anticoagulants market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Anticoagulants market. The report also includes nautical information, where it shows Anticoagulants market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Anticoagulants market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Anticoagulants market.
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
Geographical Analysis:
Based on region, the global Anticoagulants market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Anticoagulants market are
Sanofi
Bayer
Boehringer Ingelheim
Johnson & Johnson
Genentech (Roche)
AstraZeneca
Bristol-Myers Squibb
Aspen
Lilly
Otsuka
Pfizer
Daiichi Sankyo
The Medicines Company
Segment by Type
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
Segment by Application
VTE
ACS/MI
AF
Other
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anticoagulants market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Anticoagulants market.
• The market share of the global Anticoagulants market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anticoagulants market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anticoagulants market.
1 Anticoagulants Market Overview
1.1 Anticoagulants Product Scope
1.2 Anticoagulants Segment by Type
1.2.1 Global Anticoagulants Sales by Type (2020-2026)
1.2.2 Platelet aggregation inhibitors (PAI)
1.2.3 Low-molecular-weight Heparin (LMWH)
1.2.4 Direct thrombin inhibitor (DTI)
1.2.5 Direct factor Xa inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Anticoagulants Segment by Application
1.3.1 Global Anticoagulants Sales Comparison by Application (2020-2026)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Other
1.4 Anticoagulants Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anticoagulants Sales Growth Rate (2015-2026)
1.4.2 Global Anticoagulants Revenue and Growth Rate (2015-2026)
1.4.3 Global Anticoagulants Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anticoagulants Industry Impact
1.5.1 How the Covid-19 is Affecting the Anticoagulants Industry
1.5.1.1 Anticoagulants Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anticoagulants Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anticoagulants Players to Combat Covid-19 Impact
2 Anticoagulants Estimate and Forecast by Region
2.1 Global Anticoagulants Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anticoagulants Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anticoagulants Sales Market Share by Region (2015-2020)
2.2.2 Global Anticoagulants Revenue Market Share by Region (2015-2020)
2.3 Global Anticoagulants Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anticoagulants Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anticoagulants Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anticoagulants Estimates and Projections (2015-2026)
2.4.2 Europe Anticoagulants Estimates and Projections (2015-2026)
2.4.3 China Anticoagulants Estimates and Projections (2015-2026)
2.4.4 Japan Anticoagulants Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anticoagulants Estimates and Projections (2015-2026)
2.4.6 India Anticoagulants Estimates and Projections (2015-2026)
3 Global Anticoagulants Competition Landscape by Players
3.1 Global Top Anticoagulants Players by Sales (2015-2020)
3.2 Global Top Anticoagulants Players by Revenue (2015-2020)
3.3 Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulants as of 2019)
3.4 Global Anticoagulants Average Price by Company (2015-2020)
3.5 Manufacturers Anticoagulants Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anticoagulants Players (Opinion Leaders)
4 Global Anticoagulants Market Size by Type
4.1 Global Anticoagulants Historic Market Review by Type (2015-2020)
4.1.1 Global Anticoagulants Sales Market Share by Type (2015-2020)
4.1.2 Global Anticoagulants Revenue Market Share by Type (2015-2020)
4.1.3 Global Anticoagulants Price by Type (2014-2020)
4.2 Global Anticoagulants Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anticoagulants Sales Forecast by Type (2021-2026)
4.2.2 Global Anticoagulants Revenue Forecast by Type (2021-2026)
4.2.3 Global Anticoagulants Price Forecast by Type (2021-2026)
5 Global Anticoagulants Market Size by Application
5.1 Global Anticoagulants Historic Market Review by Application (2015-2020)
5.1.1 Global Anticoagulants Sales Market Share by Application (2015-2020)
5.1.2 Global Anticoagulants Revenue Market Share by Application (2015-2020)
5.1.3 Global Anticoagulants Price by Application (2015-2020)
5.2 Global Anticoagulants Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anticoagulants Sales Forecast by Application (2021-2026)
5.2.2 Global Anticoagulants Revenue Forecast by Application (2021-2026)
5.2.3 Global Anticoagulants Price Forecast by Application (2021-2026)
3 North America Anticoagulants Market Facts & Figures
3.2 North America Anticoagulants Sales Market Share by Company (2015-2020)
3.3 North America Anticoagulants Sales Market Share by Type (2015-2020)
3.4 North America Anticoagulants Sales Market Share by Application (2015-2020)
4 Europe Anticoagulants Market Facts & Figures
4.2 Europe Anticoagulants Sales Market Share by Company (2015-2020)
4.3 Europe Anticoagulants Sales Market Share by Type (2015-2020)
4.4 Europe Anticoagulants Sales Market Share by Application (2015-2020)
5 China Anticoagulants Market Facts & Figures
5.2 China Anticoagulants Sales Market Share by Company (2015-2020)
5.3 China Anticoagulants Sales Market Share by Type (2015-2020)
5.4 China Anticoagulants Sales Market Share by Application (2015-2020)
6 Japan Anticoagulants Market Facts & Figures
6.2 Japan Anticoagulants Sales Market Share by Company (2015-2020)
6.3 Japan Anticoagulants Sales Market Share by Type (2015-2020)
6.4 Japan Anticoagulants Sales Market Share by Application (2015-2020)
7 Southeast Asia Anticoagulants Market Facts & Figures
7.2 Southeast Asia Anticoagulants Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anticoagulants Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anticoagulants Sales Market Share by Application (2015-2020)
8 India Anticoagulants Market Facts & Figures
8.2 India Anticoagulants Sales Market Share by Company (2015-2020)
8.3 India Anticoagulants Sales Market Share by Type (2015-2020)
8.4 India Anticoagulants Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anticoagulants Business
12.1 Sanofi
12.1.1 Sanofi Anticoagulants Corporation Information
12.1.2 Sanofi Anticoagulants Business Overview and Total Revenue
12.1.3 Sanofi Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Anticoagulants Products Offered
12.1.5 Sanofi Recent Development
12.2 Bayer
12.2.1 Bayer Anticoagulants Corporation Information
12.2.2 Bayer Anticoagulants Business Overview and Total Revenue
12.2.3 Bayer Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Anticoagulants Products Offered
12.2.5 Bayer Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Anticoagulants Corporation Information
12.3.2 Boehringer Ingelheim Anticoagulants Business Overview and Total Revenue
12.3.3 Boehringer Ingelheim Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Anticoagulants Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Anticoagulants Corporation Information
12.4.2 Johnson & Johnson Anticoagulants Business Overview and Total Revenue
12.4.3 Johnson & Johnson Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Anticoagulants Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Genentech (Roche)
12.5.1 Genentech (Roche) Anticoagulants Corporation Information
12.5.2 Genentech (Roche) Anticoagulants Business Overview and Total Revenue
12.5.3 Genentech (Roche) Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Genentech (Roche) Anticoagulants Products Offered
12.5.5 Genentech (Roche) Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Anticoagulants Corporation Information
12.6.2 AstraZeneca Anticoagulants Business Overview and Total Revenue
12.6.3 AstraZeneca Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AstraZeneca Anticoagulants Products Offered
12.6.5 AstraZeneca Recent Development
12.7 Bristol-Myers Squibb
12.7.1 Bristol-Myers Squibb Anticoagulants Corporation Information
12.7.2 Bristol-Myers Squibb Anticoagulants Business Overview and Total Revenue
12.7.3 Bristol-Myers Squibb Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Bristol-Myers Squibb Anticoagulants Products Offered
12.7.5 Bristol-Myers Squibb Recent Development
12.8 Aspen
12.8.1 Aspen Anticoagulants Corporation Information
12.8.2 Aspen Anticoagulants Business Overview and Total Revenue
12.8.3 Aspen Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Aspen Anticoagulants Products Offered
12.8.5 Aspen Recent Development
12.9 Lilly
12.9.1 Lilly Anticoagulants Corporation Information
12.9.2 Lilly Anticoagulants Business Overview and Total Revenue
12.9.3 Lilly Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Lilly Anticoagulants Products Offered
12.9.5 Lilly Recent Development
12.10 Otsuka
12.10.1 Otsuka Anticoagulants Corporation Information
12.10.2 Otsuka Anticoagulants Business Overview and Total Revenue
12.10.3 Otsuka Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Otsuka Anticoagulants Products Offered
12.10.5 Otsuka Recent Development
12.11 Pfizer
12.11.1 Pfizer Anticoagulants Corporation Information
12.11.2 Pfizer Anticoagulants Business Overview and Total Revenue
12.11.3 Pfizer Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Anticoagulants Products Offered
12.11.5 Pfizer Recent Development
12.12 Daiichi Sankyo
12.12.1 Daiichi Sankyo Anticoagulants Corporation Information
12.12.2 Daiichi Sankyo Anticoagulants Business Overview and Total Revenue
12.12.3 Daiichi Sankyo Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Daiichi Sankyo Anticoagulants Products Offered
12.12.5 Daiichi Sankyo Recent Development
12.13 The Medicines Company
12.13.1 The Medicines Company Anticoagulants Corporation Information
12.13.2 The Medicines Company Anticoagulants Business Overview and Total Revenue
12.13.3 The Medicines Company Anticoagulants Sales, Revenue and Gross Margin (2015-2020)
12.13.4 The Medicines Company Anticoagulants Products Offered
12.13.5 The Medicines Company Recent Development
13 Anticoagulants Manufacturing Cost Analysis
13.1 Anticoagulants Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anticoagulants
13.4 Anticoagulants Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anticoagulants Distributors List
14.3 Anticoagulants Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anticoagulants Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Anticoagulants Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anticoagulants Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anticoagulants Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anticoagulants Players to Combat Covid-19 Impact
Table 8. Global Market Anticoagulants Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anticoagulants Sales (K MT) by Region (2015-2020)
Table 10. Global Anticoagulants Sales Market Share by Region (2015-2020)
Table 11. Global Anticoagulants Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anticoagulants Revenue Share by Region (2015-2020)
Table 13. Global Anticoagulants Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Anticoagulants Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anticoagulants Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anticoagulants Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anticoagulants (K MT) of Key Companies (2015-2020)
Table 18. Global Anticoagulants Sales Share by Company (2015-2020)
Table 19. Global Anticoagulants Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anticoagulants Revenue Share by Company (2015-2020)
Table 21. Global Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulants as of 2019)
Table 22. Global Anticoagulants Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Anticoagulants Manufacturing Sites and Area Served
Table 24. Manufacturers Anticoagulants Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anticoagulants Players
Table 27. Global Anticoagulants Sales (K MT) by Type (2015-2020)
Table 28. Global Anticoagulants Sales Share by Type (2015-2020)
Table 29. Global Anticoagulants Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anticoagulants Price (K MT) by Type (2015-2020)
Table 31. Global Anticoagulants Sales Share by Type (2021-2026)
Table 32. Global Anticoagulants Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anticoagulants Revenue Share by Type (2021-2026)
Table 34. Global Anticoagulants Price (K MT) by Type (2021-2026)
Table 35. Global Anticoagulants Sales (K MT) by Application (2015-2020)
Table 36. Global Anticoagulants Sales Share by Application (2015-2020)
Table 37. Global Anticoagulants Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anticoagulants Price (K MT) by Application (2015-2020)
Table 39. Global Anticoagulants Sales (K MT) by Application (2021-2026)
Table 40. Global Anticoagulants Sales Share by Application (2021-2026)
Table 41. Global Anticoagulants Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anticoagulants Revenue Share by Application (2021-2026)
Table 43. Global Anticoagulants Price (K MT) by Application (2021-2026)
Table 44. United States Anticoagulants Sales (K MT) by Company (2015-2020)
Table 45. United States Anticoagulants Sales Market Share by Company (2015-2020)
Table 46. United States Anticoagulants Sales (K MT) by Type (2015-2020)
Table 47. United States Anticoagulants Sales Market Share by Type (2015-2020)
Table 48. United States Anticoagulants Sales (K MT) by Application (2015-2020)
Table 49. United States Anticoagulants Sales Market Share by Application (2015-2020)
Table 50. Europe Anticoagulants Sales (K MT) by Company (2015-2020)
Table 51. Europe Anticoagulants Sales Market Share by Company (2015-2020)
Table 52. Europe Anticoagulants Sales (K MT) by Type (2015-2020)
Table 53. Europe Anticoagulants Sales Market Share by Type (2015-2020)
Table 54. Europe Anticoagulants Sales (K MT) by Application (2015-2020)
Table 55. Europe Anticoagulants Sales Market Share by Type (2015-2020)
Table 56. China Anticoagulants Sales (K MT) by Company (2015-2020)
Table 57. China Anticoagulants Sales Market Share by Company (2015-2020)
Table 58. China Anticoagulants Sales (K MT) by Type (2015-2020)
Table 59. China Anticoagulants Sales Market Share by Type (2015-2020)
Table 60. China Anticoagulants Sales (K MT) by Application (2015-2020)
Table 61. China Anticoagulants Sales Market Share by Application (2015-2020)
Table 62. Japan Anticoagulants Sales (K MT) by Company (2015-2020)
Table 63. Japan Anticoagulants Sales Market Share by Company (2015-2020)
Table 64. Japan Anticoagulants Sales (K MT) by Type (2015-2020)
Table 65. Japan Anticoagulants Sales Market Share by Type (2015-2020)
Table 66. Japan Anticoagulants Sales (K MT) by Application (2015-2020)
Table 67. Japan Anticoagulants Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anticoagulants Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Anticoagulants Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anticoagulants Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Anticoagulants Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anticoagulants Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Anticoagulants Sales Market Share by Application (2015-2020)
Table 74. India Anticoagulants Sales (K MT) by Company (2015-2020)
Table 75. India Anticoagulants Sales Market Share by Company (2015-2020)
Table 76. India Anticoagulants Sales (K MT) by Type (2015-2020)
Table 77. India Anticoagulants Sales Market Share by Type (2015-2020)
Table 78. India Anticoagulants Sales (K MT) by Application (2015-2020)
Table 79. India Anticoagulants Sales Market Share by Application (2015-2020)
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi Anticoagulants Product
Table 84. Sanofi Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Bayer Anticoagulants Product
Table 89. Bayer Recent Development
Table 90. Boehringer Ingelheim Corporation Information
Table 91. Boehringer Ingelheim Description and Business Overview
Table 92. Boehringer Ingelheim Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Boehringer Ingelheim Anticoagulants Product
Table 94. Boehringer Ingelheim Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Anticoagulants Product
Table 99. Johnson & Johnson Recent Development
Table 100. Genentech (Roche) Corporation Information
Table 101. Genentech (Roche) Description and Business Overview
Table 102. Genentech (Roche) Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Genentech (Roche) Anticoagulants Product
Table 104. Genentech (Roche) Recent Development
Table 105. AstraZeneca Corporation Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. AstraZeneca Anticoagulants Product
Table 109. AstraZeneca Recent Development
Table 110. Bristol-Myers Squibb Corporation Information
Table 111. Bristol-Myers Squibb Description and Business Overview
Table 112. Bristol-Myers Squibb Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Bristol-Myers Squibb Anticoagulants Product
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Aspen Corporation Information
Table 116. Aspen Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Aspen Description and Business Overview
Table 118. Aspen Anticoagulants Product
Table 119. Aspen Recent Development
Table 120. Lilly Corporation Information
Table 121. Lilly Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Lilly Description and Business Overview
Table 123. Lilly Anticoagulants Product
Table 124. Lilly Recent Development
Table 125. Otsuka Corporation Information
Table 126. Otsuka Description and Business Overview
Table 127. Otsuka Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Otsuka Anticoagulants Product
Table 129. Otsuka Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Pfizer Anticoagulants Product
Table 134. Pfizer Recent Development
Table 135. Daiichi Sankyo Corporation Information
Table 136. Daiichi Sankyo Description and Business Overview
Table 137. Daiichi Sankyo Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Daiichi Sankyo Anticoagulants Product
Table 139. Daiichi Sankyo Recent Development
Table . The Medicines Company Corporation Information
Table . The Medicines Company Description and Business Overview
Table . The Medicines Company Anticoagulants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . The Medicines Company Anticoagulants Product
Table . The Medicines Company Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Anticoagulants Distributors List
Table 148. Anticoagulants Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulants Product Picture
Figure 2. Global Anticoagulants Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anticoagulants Market Share by Application in 2020 & 2026
Figure 6. VTE Examples
Figure 7. ACS/MI Examples
Figure 8. AF Examples
Figure 9. Other Examples
Figure 10. Global Anticoagulants Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Anticoagulants Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Anticoagulants Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Anticoagulants Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Anticoagulants Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Anticoagulants Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Anticoagulants Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Anticoagulants Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Anticoagulants Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Anticoagulants Players Market Share by Revenue in Anticoagulants 2015 & 2019
Figure 28. Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Anticoagulants Revenue Share by Type (2015-2020)
Figure 30. Global Anticoagulants Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Anticoagulants Revenue Share by Application (2015-2020)
Figure 32. Global Anticoagulants Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Anticoagulants Sales Market Share by Type in 2019
Figure 34. United States Anticoagulants Sales Market Share by Type in 2019
Figure 35. Europe Anticoagulants Sales Market Share by Company in 2019
Figure 36. Europe Anticoagulants Sales Market Share by Type in 2019
Figure 37. Europe Anticoagulants Sales Market Share by Application in 2019
Figure 38. China Anticoagulants Sales Market Share by Company in 2019
Figure 39. China Anticoagulants Sales Market Share by Type in 2019
Figure 40. China Anticoagulants Sales Market Share by Application in 2019
Figure 41. Japan Anticoagulants Sales Market Share by Company in 2019
Figure 42. Japan Anticoagulants Sales Market Share by Type in 2019
Figure 43. Japan Anticoagulants Sales Market Share by Application in 2019
Figure 44. Southeast Asia Anticoagulants Sales Market Share by Company in 2019
Figure 45. Southeast Asia Anticoagulants Sales Market Share by Type in 2019
Figure 46. Southeast Asia Anticoagulants Sales Market Share by Application in 2019
Figure 47. India Anticoagulants Sales Market Share by Company in 2019
Figure 48. India Anticoagulants Sales Market Share by Type in 2019
Figure 49. India Anticoagulants Sales Market Share by Application in 2019
Figure 50. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. The Medicines Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Anticoagulants
Figure 65. Manufacturing Process Analysis of Anticoagulants
Figure 66. Anticoagulants Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
注射用抗凝固剤の世界市場レポート2020 A recently published report by QY Research titled Global Injectable Anticoagulants Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides a…- 低分子量ヘパリンナトリウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Low Molecular Weight Heparin Sodium market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Low Molec…
- 腫瘍壊死因子アルファ阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Tumor Necrosis Factor Alpha Inhibitors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor …
- ネズミ駆除の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Rodent Control market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rodent Control market report p…
- スケール防止剤/スケール抑制剤の世界市場レポート2020 Market Analysis and Insights: Global Antiscalants/Scale Inhibitors Market The global Antiscalants/Scale Inhibitors market was valued at US$ 2326.5 million in 2019 and will reach US$ 2805.9 million by the end of 2026, growing at a CAGR of 2.7% during 2020-2026. Global Antiscalants/Scale Inhibitors Sc…